Monocyte chemotactic protein 1 increases homing of mesenchymal stem cell to injured myocardium and neovascularization following myocardial infarction

被引:0
|
作者
Yu Zhuang Xin Chen~* Kaihu Shi Ming Xu Department of Thoracic & Cardiovascular Surgery the Nanjing First Hospital Affiliated to Nanjing Medical University
机构
关键词
mesenchymal stem cells; homing; myocardial infarction; cardiac function; monocyte chemotactic protein 1;
D O I
暂无
中图分类号
R542.22 [];
学科分类号
1002 ; 100201 ;
摘要
Objective:To investigate the effect of MCP-1 on mesenchymal stem cells(MSCs) homing to injured myocardium in a rat myocardial infarction(MI) model.Methods:Rat myocardial infarction model was established by permanent left anterior descending branch ligation. Mesenchymal stem cells from donor rats were cultured in IMDM and labeled with BrdU.The Rats were divided into two groups. Monocyte chemotactic protein 1(MCP-I) expression were measured by in situ hybridization and immunohistochemistry in the sham operated or infarcted hearts at 1,2,4,7,14 and 28 days post operation in MCP-1 detection group.The rats were injected with MCP-1, anti-MCP-1 antibody or saline 4 days after myocardial infarction in intervention group.Then,a total of 5×10~6 cells in 2.5 ml of PBS were injected through the tail vein.The number of the labeled MSCs in the infarcted hearts was counted 3 days post injection.Cardiac function and blood vessel density were assessed 28 days post injection.Results:Self-generating MCP-1 expression was increased at the first day,peaked at the 7day and decreased thereafter post MI and remained unchanged in sham operated hearts.The MSCs enrichment in the host hearts were more abundant in the MI groups than that in the non-MI group(P=0.000),the MSCs enrichment in the host hearts were more abundant in the MCP-1 injected group than that in the anti-MCP-1 antibody and saline injected groups (P=0.000).Cardiac function was improved more in MCP-1 injected group than anti-MCP-1 antibody and saline injected groups(P=0.000). Neovascularization in MCP-1 injected group significantly increased compared with that of other groups(P=0.000).Conclusion: Myocardial MCP-1 expression was increased only in the early phase post MI.MCP-1 may enhance MSCs homing to the injured heart and improve cardiac function by promoting neovascularization.
引用
收藏
页码:311 / 316
页数:6
相关论文
共 50 条
  • [41] Bone Marrow-Derived Mononuclear Cell Transfer Is Associated with Superior Cardiac Recovery and Neovascularization as Compared to Nonmodified Mesenchymal Stem Cell Therapy in Chronic Myocardial Infarction
    Mathieu, Myrielle
    El Oumeiri, Bachar
    Touihri, Karim
    Thoma, Philippe
    Meters, Thierry
    Hadad, Ielham
    Ray, Lynn
    Mazouz, Naima
    Naeije, Robert
    Heydrickx, Guy
    Bartunek, Jozef
    Mc Entee, Kathleen
    CIRCULATION, 2008, 118 (18) : S790 - S790
  • [42] Mesenchymal Stem Cell-Derived Extracellular Vesicle Therapy Delivered in a Hydrogel Preserves Hemodynamic Function Following Myocardial Infarction
    Helmers, Mark R.
    Jarmula, Jakub
    Kim, Samuel
    Schiazza, Alexis
    Altshuler, Peter
    Burdick, Jason A.
    Atluri, Pavan
    CIRCULATION, 2020, 142
  • [43] Mesenchymal Stem Cells Engineered with Integrin-Linked Kinase Improves Cardiac Function Paralleled with Enhanced Homing Capacity Following Intracoronary Transplantation in Porcine Myocardial Infarction
    Xu, Biao
    Mu, Dan
    Zhang, Xinlin
    Xie, Jun
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 66 (16) : C133 - C133
  • [44] MESENCHYMAL STEM CELL SUPPRESSES THE INFILTRATION OF PERIPHERAL IMMUNE CELLS VIA MONOCYTE CHEMOATTRACTANT PROTEIN-1 SUPPRESSION
    Yoo, S. W.
    Lee, H. S.
    Kim, S. S.
    Cho, S. K.
    Hong, S. Y.
    Joe, E. H.
    Lee, Y. D.
    Suh-Kim, H.
    JOURNAL OF NEUROCHEMISTRY, 2009, 110 : 263 - 263
  • [45] Changes in circulating mesenchymal stem cells, stem cell homing factor, and vascular growth factors in patients with acute ST elevation myocardial infarction treated with primary percutaneous coronary intervention
    Wang, Y.
    Johnsen, H. E.
    Mortensen, S.
    Bindslev, L.
    Ripa, R. Sejersten
    Haack-Sorensen, M.
    Jorgensen, E.
    Fang, W.
    Kastrup, J.
    HEART, 2006, 92 (06) : 768 - 774
  • [46] A theoretical timeline for myocardial infarction: immunohistochemical evaluation and western blot quantification for Interleukin-15 and Monocyte chemotactic protein-1 as very early markers
    Turillazzi, Emanuela
    Di Paolo, Marco
    Neri, Margherita
    Riezzo, Irene
    Fineschi, Vittorio
    JOURNAL OF TRANSLATIONAL MEDICINE, 2014, 12
  • [47] A theoretical timeline for myocardial infarction: immunohistochemical evaluation and western blot quantification for Interleukin-15 and Monocyte chemotactic protein-1 as very early markers
    Emanuela Turillazzi
    Marco Di Paolo
    Margherita Neri
    Irene Riezzo
    Vittorio Fineschi
    Journal of Translational Medicine, 12
  • [48] Cardiac Stem Cell Secretome Protects Cardiomyocytes from Hypoxic Injury Partly via Monocyte Chemotactic Protein-1-Dependent Mechanism
    Park, Chi-Yeon
    Choi, Seung-Cheol
    Kim, Jong-Ho
    Choi, Ji-Hyun
    Joo, Hyung Joon
    Hong, Soon Jun
    Lim, Do-Sun
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2016, 17 (06):
  • [49] Respiratory syncytial virus infection increases regulated on activation normal T cell expressed and secreted and monocyte chemotactic protein 1 levels in serum of patients with asthma and in human monocyte cultures
    Gotera, Jenifer
    Giuffrida, Maria
    Mavarez, Alibeth
    Pons, Hector
    Bermudez, John
    Maldonado, Mery
    Espina, Luz Marina
    Mosquera, Jesus
    Valero, Nereida
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2012, 108 (05) : 316 - 320
  • [50] Thioredoxin-1 (Trx1) engineered mesenchymal stem cell therapy is a promising feasible therapeutic approach for myocardial infarction
    Yang, Chao-Jun
    Yang, Jun
    Yang, Jian
    Fan, Zhi-Xing
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 206 : 169 - 170